{
    "clinical_study": {
        "@rank": "48778", 
        "arm_group": [
            {
                "arm_group_label": "Mesenchymal stem cell receipients", 
                "arm_group_type": "Experimental", 
                "description": "Transplantation of allogenic adipose derived mesenchymal stem cells in patients with tibial fracture."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo injection in the site of fracture in patients with tibia fracture."
            }
        ], 
        "brief_summary": {
            "textblock": "This study is a case-control prospective, clinal trial to assess the safety and efficacy of\n      the allogeneic adipose derived mesenchymal stem cell transplantation on the healing of\n      recent tibial fracture in 40 patients."
        }, 
        "brief_title": "Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Tibial Fracture", 
        "condition_browse": {
            "mesh_term": [
                "Fractures, Bone", 
                "Tibial Fractures"
            ]
        }, 
        "detailed_description": {
            "textblock": "In this study all eligible patients divided in 2 group.20 patients received allogeneic\n      adipose derived mesenchymal stem cell in the fractured site (case group) and other patients\n      received  the placebo in the fractured site (control group) .\n\n      To assess the outcomes, we will evaluate the patients at 2, 6 weeks and 3, 6 months after\n      transplantation by: X-ray, BMD , VAS and biochemical analysis with laboratory tests."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 to 65 years\n\n          -  The presence of tibial fracture based on X ray\n\n          -  tibial fracture is limited to diaphysial\n\n        Exclusion Criteria:\n\n          -  Addiction\n\n          -  Pregnancy\n\n          -  liver or kidney disease or uncontrolled diabetes or heart and lung disease\n\n          -  immune deficiency"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02140528", 
            "org_study_id": "Royan-Bone-012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Mesenchymal stem cell receipients", 
                "description": "Injection of adipose derived mesenchymal stem cell in the site of tibia fracture .", 
                "intervention_name": "Mesenchymal stem cell injection", 
                "intervention_type": "Biological", 
                "other_name": "stem cell transplantation"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "Allogenic adipose derived mesenchymal stem cell tibial fracture", 
        "lastchanged_date": "May 15, 2014", 
        "link": {
            "url": "http://Royaninstitute.org"
        }, 
        "location": {
            "contact": {
                "email": "nasser.aghdami@royaninstitute.org", 
                "last_name": "Nasser Aghdami, MD,PhD", 
                "phone": "(+98)2123562000", 
                "phone_ext": "516"
            }, 
            "contact_backup": {
                "email": "Leara91@gmail.com", 
                "last_name": "Leila Arab, MD", 
                "phone": "(+98)23562000", 
                "phone_ext": "414"
            }, 
            "facility": {
                "address": {
                    "city": "Tehran", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Royan Institute"
            }, 
            "investigator": [
                {
                    "last_name": "Neda Jarooghi, MSc", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Soura Mardpour, MSc", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Tina Bolourieh, MSc", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation the Safety and Efficacy of Allogeneic Mesenchymal Stem Cell Transplantation in Tibial Closed Diaphyseal Fractures", 
        "overall_contact": {
            "email": "nasser.aghdami@royaninstitute.org", 
            "last_name": "Nasser Aghdami, MD,PhD", 
            "phone": "(+98)23562000", 
            "phone_ext": "516"
        }, 
        "overall_contact_backup": {
            "email": "Leara91@gmail.com", 
            "last_name": "Leila Arab, MD", 
            "phone": "(+98)23562000", 
            "phone_ext": "414"
        }, 
        "overall_official": [
            {
                "affiliation": "Head of Royan Institute", 
                "last_name": "Hamid Gourabi, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Head of regenerative medicine department &cell therapy center of Royan Institute", 
                "last_name": "Nasser Aghdami, MD,PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Department or regenerative medicine of Royan Institute.", 
                "last_name": "Mohsen Emaddedin, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Scientific board of Iranian Orthopedic Association", 
                "last_name": "Aziz Ahmadi, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Regenerative Medicine", 
                "last_name": "Maedeh Ghorbani, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Scientific board of Iranian Orthopedic Association", 
                "last_name": "Afshin Farhadi, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Iran: Ethics Committee", 
                "Iran: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of patients with union after transplantation of mesenchymal stem  cell in case group in comparison with control group", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02140528"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Royan Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Royan Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}